Your health is your most valuable asset.

Invest in it wisely.

Dr Timothy Middleton

BSc (Adv) Hons I, MBBS, PhD, MPhil, FRACP

Endocrinologist

Dr. Timothy Middleton is an endocrinologist trained in Sydney, with a special interest in diabetes mellitus. He graduated with honours from the University of Sydney, holding degrees in Bachelor of Science (Adv) with First Class Honors and Bachelor of Medicine and Bachelor of Surgery (MBBS).

Dr. Middleton completed his advanced training in endocrinology at Concord Repatriation General Hospital and Royal Prince Alfred Hospital. He furthered his academic pursuits by completing a Master of Philosophy (Medicine) where he examined the cardiac effects of sulfonylurea-related hypoglycemia. Subsequently, he obtained his PhD, focusing on young adult-onset type 2 diabetes. Dr. Middleton is deeply committed to training the next generation of medical professionals and holds an Honorary Clinical Lecturer position at the University of Sydney.

With his expertise in the field, Dr. Middleton has served as a peer reviewer for renowned journals such as Diabetes Care and the Journal of Diabetes and Its Complications. He is an active member of the Australian Diabetes Society and the Endocrine Society of Australia. Currently, he serves as a staff specialist at the Royal Prince Alfred Hospital Diabetes Centre and the Collaborative Centre for Cardiometabolic Health in Psychosis Service within the Sydney Local Health District. Additionally, he is accredited as an endocrinologist at Sydney Adventist Hospital and Northern Beaches Hospital where he provides outpatient care. Dr. Middleton is dedicated to delivering high-quality, evidence-based care to all of his patients.

Dr. Middleton's research interests focus on improving understanding of diabetic complications and enhancing the management of diabetes mellitus through the integration of emerging technologies and novel treatment strategies. In recognition of his research endeavors, he was awarded a Department of Health, Medical Research Future Fund, Rapid Applied Research Translation Grant in 2019. The project aimed to evaluate the effectiveness of an enhanced SMS-based support and reminder program in the context of young adult-onset type 2 diabetes.